Avinger (NASDAQ:AVGR) Coverage Initiated at StockNews.com

Investment analysts at StockNews.com initiated coverage on shares of Avinger (NASDAQ:AVGR) in a research note issued to investors on Saturday. The firm set a “hold” rating on the medical device company’s stock.

Avinger Stock Performance

Shares of NASDAQ:AVGR opened at $0.47 on Friday. The company has a fifty day simple moving average of $0.64 and a 200 day simple moving average of $0.85. The firm has a market cap of $1.57 million, a PE ratio of -0.04 and a beta of 1.09. Avinger has a 12-month low of $0.36 and a 12-month high of $5.45.

Avinger Company Profile

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.